prof. dr. S. (Steven) de Jong

Professor

prof. dr. S. (Steven) de Jong
E-mail:
s.de.jong umcg.nl

Research

  1. 2020
  2. 2019
  3. 2018
  4. Berns, K., Caumanns, J. J., Hijmans, E. M., Gennissen, A. M. C., Severson, T. M., Evers, B., ... Bernards, R. (2018). ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors. ONCOGENE, 37(33), 4611-4625. https://doi.org/10.1038/s41388-018-0300-6
  5. 2017
  6. Byrne, A. T., Alferez, D. G., Amant, F., Annibali, D., Arribas, J., Biankin, A. V., ... EurOPDX Consortium (2017). Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nature reviews cancer, 17(4), 254-268. https://doi.org/10.1038/nrc.2016.140
  7. 2016
  8. 2015
  9. 2014
  10. Hidalgo, M., Amant, F., Biankin, A. V., Budinska, E., Byrne, A. T., Caldas, C., ... EurOPDX Consortium (2014). Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research. Cancer discovery, 4(9), 998-1013. https://doi.org/10.1158/2159-8290.CD-14-0001
  11. 2013
  12. 2012
Previous 1 2 3 4 Next

ID: 94427